Hosted on MSN3d
Here's Why You Should Consider Buying Atara Biotherapeutics Stock
Atara Biotherapeutics ATRA is a nimble allogeneic T cell immunotherapy company with several near-term catalysts. This Zacks ...
Hosted on MSN9d
Atara Biotherapeutics (ATRA) Upgraded to Buy: Here's Why
Atara Biotherapeutics (ATRA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...
Atara Biotherapeutics, Inc.'s (NASDAQ:ATRA) high institutional ownership speaks for itself as stock continues to impress, up 27% over last week
A look at the shareholders of Atara Biotherapeutics, Inc. ( NASDAQ:ATRA) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with 48% ...
Nasdaq19d
Atara Biotherapeutics, Inc. Common Stock (ATRA) Insider Activity
Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...
Biotech Stocks Facing FDA Decision In January 2025
As we enter the new year, all eyes are on the biotech companies awaiting key FDA decisions in January. In 2024, the FDA approved 50 ...